Oruka Therapeutics Investigative Site

New York, New York 10029

2 studies enrolling now · 3 studies all time

What they study most

Plaque Psoriasis

Studies at this site

• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis — Recruiting now
• An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis — Recruiting now
• ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling